Contact this trialFirst, we need to learn more about you.
Alpha-2 Adrenergic Receptor Agonist
Dexmedetomidine for Agitation in Schizophrenia and Bipolar Disorder
Recruiting1 awardPhase 3
DeSoto, Texas
This trial tests an investigational medication for treating episodes of agitation in bipolar I/II, schizophrenia, schizoaffective and schizophreniform disorder. It compares the drug to a placebo.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.